Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Regulation of Chemotherapy Induced Pain by Extracellular Matrix Degradation
FY 2023-24
Summary
Around 70% of chemotherapy patients experience chemotherapy-induced peripheral neuropathy, marked by persistent pain suggesting long-lasting nervous system changes. Platinum-based chemotherapeutics, like cisplatin, accumulate in the dorsal root ganglia, which are peripheral nervous system structures along to spine containing the cell bodies of pain sensing neurons. The cell bodies of sensory neurons and their support cells live in a meshwork of molecules called the extracellular matrix. Although the extracellular matrix of the brain and spinal cord is known to regulate the activity of neurons, less is known about its role in the dorsal root ganglia. Yet, changes in the matrix composition are linked to pain-like behaviour in mice with paw inflammation. My preliminary experiments have found that as pain-like behaviour develops in mice treated with cisplatin, there is a loss of type 1 collagen, a major structural component of the extracellular matrix, in the dorsal root ganglia. Thus, changes in the extracellular matrix could underlie pain from chemotherapy. My hypothesis is that cisplatin stimulates immune cells to degrade the extracellular matrix of the dorsal root ganglia, which causes long lasting neuronal hypersensitivity and pain. I will test my hypothesis by using the cisplatin mouse model of chemotherapy-induced peripheral neuropathy. Matrix changes and immune cell activity will be assessed using mass spectrometry, 3D staining, light sheet microscopy and machine vision. I will then determine which immune cells degrade the matrix to cause pain-like behaviour. Understanding how cisplatin-induced pain is underpinned by extracellular matrix remodelling will open the door to new pain management strategies like tissue engineering repair of the matrix.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
505830
Name
Alhamwi Allutas
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Regulation of Chemotherapy Induced Pain by Extracellular Matrix Degradation
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chemotherapy-Induced Peripheral Neuropathy; Collagen Type 1; Dorsal Root Ganglia; Extracellular Matrix Degrading Proteases; Extracellular Matrix Remodelling; Fibroblasts And Satellite Glial Cells; Immune Cells; Neuronal Hypersensitivity; Pain-Like Behaviour; Platinum-Based Chemotherapeutics
Abstract
Around 70% of chemotherapy patients experience chemotherapy-induced peripheral neuropathy, marked by persistent pain suggesting long-lasting nervous system changes. Platinum-based chemotherapeutics, like cisplatin, accumulate in the dorsal root ganglia, which are peripheral nervous system structures along to spine containing the cell bodies of pain sensing neurons. The cell bodies of sensory neurons and their support cells live in a meshwork of molecules called the extracellular matrix. Although the extracellular matrix of the brain and spinal cord is known to regulate the activity of neurons, less is known about its role in the dorsal root ganglia. Yet, changes in the matrix composition are linked to pain-like behaviour in mice with paw inflammation. My preliminary experiments have found that as pain-like behaviour develops in mice treated with cisplatin, there is a loss of type 1 collagen, a major structural component of the extracellular matrix, in the dorsal root ganglia. Thus, changes in the extracellular matrix could underlie pain from chemotherapy. My hypothesis is that cisplatin stimulates immune cells to degrade the extracellular matrix of the dorsal root ganglia, which causes long lasting neuronal hypersensitivity and pain. I will test my hypothesis by using the cisplatin mouse model of chemotherapy-induced peripheral neuropathy. Matrix changes and immune cell activity will be assessed using mass spectrometry, 3D staining, light sheet microscopy and machine vision. I will then determine which immune cells degrade the matrix to cause pain-like behaviour. Understanding how cisplatin-induced pain is underpinned by extracellular matrix remodelling will open the door to new pain management strategies like tissue engineering repair of the matrix.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Alhamwi, Allutas
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~